Allogeneic (allo) hematopoietic cell transplantation (HCT) is the only curative treatment
option for patients suffering from chemotherapy-refractory or relapsed hematological …

Hematopoietic cell transplantation is an established curative treatment option for various
hematological malignant, and non-malignant diseases. However, the success of HCT is still …

The outcome of allogeneic hematopoietic cell transplantation (allo-HCT) largely depends on
the development and management of graft-versus-host disease (GvHD), infections, and the …

Gamma delta (γδ) T cells are a highly heterogeneous population of lymphocytes that exhibit
innate and adaptive immune properties. Despite comprising the majority of residing …

The role of gamma delta (γδ) T cells in human cytomegalovirus (HCMV) immune
surveillance has been the focus of research interest for years. Recent reports have shown a …

Although the impact of donor graft composition on clinical outcomes after hematopoietic
stem cell transplantation (HSCT) has been studied, little is known about the role of intragraft …

Graft‐versus‐host disease (GvHD) is a common, morbid complication after intestinal
transplantation (ITx) with poorly understood pathophysiology. Resident memory T cells …

The impact of intra-graft T cells on the clinical outcome after allogeneic hematopoietic cell
transplantation has been investigated. Most previous studies have focused on the role of αβ …

Allogeneic stem cell transplantation (alloSCT) is a highly effective treatment method for
haematologic malignancies. However, infection of acute organ dysfunction and graft versus …

Background Graft‐versus‐host disease (GVHD) and relapse remain majobstacles ftreatment
success in allogeneic hematopoietic stem cell transplantation (HSCT). In the present study …